×
ADVERTISEMENT
ADVERTISEMENT

Hyderabad's Bharat Biotech partners with GSK to lead development of Shigella vaccine

The agreement marks a critical step in the advancement of this promising vaccine, targeting Shigellosis—a severe form of bacterial diarrhoea that disproportionately affects children under five in low- and middle-income countries.
Last Updated : 12 June 2025, 16:00 IST
ADVERTISEMENT

Follow Us :

Comments
ADVERTISEMENT
Published 12 June 2025, 16:00 IST

Follow us on :

Follow Us